Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer

S Walker, J Walker, G Richardson, S Palmer, Q Wu, S Gilbody, P Martin, C Holm Hansen, A Sawhney, G Murray, M Sculpher, M Sharpe

Research output: Contribution to journalArticlepeer-review


Co-morbid major depression occurs in approximately 10% of people suffering from a chronic medical condition such as cancer. Systematic integrated management that includes both identification and treatment has been advocated. However, we lack information on the cost-effectiveness of this combined approach, as published evaluations have focused solely on the systematic (collaborative care) treatment stage. We therefore aimed to use the best available evidence to estimate the cost-effectiveness of systematic integrated management (both identification and treatment) compared with usual practice, for patients attending specialist cancer clinics.
Original languageEnglish
Pages (from-to)1451-1460
Number of pages10
JournalPsychological Medicine
Issue number7
Early online date21 Aug 2013
Publication statusPublished - Apr 2014

Bibliographical note

© 2013, Cambridge University Press.

Cite this